Clinical Trial Update: A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the hypoglycemia response in participants with Type 2 Diabetes Mellitus treated with once-weekly retatrutide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: ACTIVE_NOT_RECRUITING